EW vs KEY · P/E 47, rev $1.39B vs P/E 13, rev $7.51B
Edwards Lifesciences Corp (EW) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
EW currently screens at market cap $49.91B and trailing P/E 46.9. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the EW and KEY stock pages for the full models.
Not investment advice.